首页> 外国专利> Human monoclonal antibody against costimulatory Molecule ailim Signal transducing and pharmaceutical use of the same

Human monoclonal antibody against costimulatory Molecule ailim Signal transducing and pharmaceutical use of the same

机译:抗共刺激分子ailim的人单克隆抗体信号转导及其药物用途

摘要

Immunization of Transgenic Mice producing Human Antibodies, created through genetic engineering techniques.With the ailim Molecule as Antigen to obtain various human monoclonal Antibodies capable of binding to ailim and capable of Controlling a variety of Biological reactions (For exampleThe Cell Proliferation, cytokine Production, cell death, histolysis immune Induction of ADCC, etc.) associated with the costimulatory Signal Transduction mediated by ailim (the secondary).Even More,It has been discovered that the human monoclonal antibody is effective for the treatment and Preservation of various Diseases associated with costimulatory Signal Transduction mediated by AILim, and can inhibit the initiation and / or progression of these diseases.
机译:通过基因工程技术对产生人类抗体的转基因小鼠进行免疫接种。以ailim分子作为抗原获得各种能够与ailim结合并能够控制多种生物学反应(例如细胞增殖,细胞因子产生,死亡,组织蛋白酶免疫诱导的ADCC等与ailim(次级)介导的共刺激信号转导有关。甚至,人们发现人单克隆抗体对于治疗和保存与共刺激有关的各种疾病有效由AILim介导的信号转导,可以抑制这些疾病的发生和发展。

著录项

  • 公开/公告号AR028927A1

    专利类型

  • 公开/公告日2003-05-28

    原文格式PDF

  • 申请/专利权人 JAPAN TOBACCO INC.;

    申请/专利号AR2001P102353

  • 发明设计人

    申请日2001-05-17

  • 分类号C07K16/28;A61K31/395;C12N15/13;C12N15/11;C12N5/20;G01N33/543;

  • 国家 AR

  • 入库时间 2022-08-22 00:04:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号